Racial differences in the relationship between surgical choice and subsequent patient-reported satisfaction outcomes among women with early-stage hormone-positive breast cancer.

Breast Cancer Research and Treatment
Prudvi ArabandiVanessa Sheppard

Abstract

The last fifteen years has seen a rising proportion of women who are eligible for breast conserving therapy (BCT) choosing mastectomy despite equivalent survival in early-stage breast cancer. We aim to explore potential racial differences in the association of surgical choice with subsequent patient-reported satisfaction outcomes. Women who were within one year of diagnosis with hormone receptor (HR)-positive breast cancer were asked the Short Version of Patient Satisfaction Questionnaire (PSQ-18), which assesses their overall satisfaction with their medical care. We conducted bivariate analyses, including paired t-tests, to clarify differences in these patient-reported factors by surgical choice and race. Multivariable linear regression models were used to adjust for clinical and demographic control variables. For the sample of 279 women who underwent definitive surgery, women who received a mastectomy had lower levels of overall satisfaction, 71 vs. 75 (out of 90) (p = .001). In stratifying this relationship by race, the difference in total satisfaction score was largest among Black women (69 among mastectomy patients vs. 75 among BCT patients; p = 0.016). On multivariable linear regression, Black race and mastectomy status (...Continue Reading

References

Apr 23, 1992·The New England Journal of Medicine·A B NattingerJ S Goodwin
Oct 19, 2000·Journal of the National Cancer Institute·C DunmoreR Millikan
Feb 27, 2001·Journal of Surgical Oncology·S BenedictP Baron
Apr 4, 2002·Journal of the National Cancer Institute·Cathy J BradleyCaralee Roberts
May 8, 2007·International Journal of Radiation Oncology, Biology, Physics·Joseph Tung-Chieh ChangAnn-Joy Cheng
Dec 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rachel A FreedmanNancy L Keating
Dec 5, 2009·Archives of Gynecology and Obstetrics·Jing HanPeter Hillemanns
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stacey A FedewaStephen B Edge
Sep 8, 2011·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Lixin SongAngelo D Moore
Nov 22, 2012·Medical Care Research and Review : MCRR·Cheryl RathertSuzanne Austin Boren
Feb 23, 2013·Journal of Women's Health·Maire Brid Mac BrideDietlind L Wahner-Roedler
Nov 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nynikka R A PalmerKathryn E Weaver
Nov 20, 2014·JAMA Surgery·Kristy L KummerowMary A Hooks
May 29, 2015·Plastic and Reconstructive Surgery·Claudia R AlbornozMonica Morrow
Oct 30, 2015·CA: a Cancer Journal for Clinicians·Carol E DeSantisAhmedin Jemal
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
May 8, 2016·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Vanessa B SheppardKepher H Makambi
Nov 18, 2017·Journal of Cancer Survivorship : Research and Practice·Vanessa B SheppardMahlet Tadesse

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Related Papers

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
N Johns, J M Dixon
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
S HofvindL A Akslen
© 2021 Meta ULC. All rights reserved